TB-Free India: JOSH Campaign, AI-Based Screening and the Road Ahead | UPSC Prelims 2026

GNM Global Nexus Media | UPSC Special

Published: 15 October 2026
Subject: Current Affairs | Health | Government Initiatives | Science & Technology
UPSC Syllabus: GS Paper II — Issues relating to health and social-sector initiatives; GS Paper III — Science and Technology and its applications.

Why in News?

India’s efforts to eliminate tuberculosis (TB) have received renewed attention following a Press Information Bureau (PIB) update published on 13 October 2026. The government highlighted progress in TB screening, treatment coverage, preventive treatment, community participation and the use of technology.

The update also highlighted JOSH (Joint Squad for Health), a campaign intended to mobilise young people and communities to promote TB awareness, early detection, timely treatment and treatment adherence, while addressing the stigma associated with the disease.

For UPSC aspirants, this development links public health policy with government programmes, infectious diseases, artificial intelligence (AI), preventive healthcare and community participation.

Official source: PIB — Towards a TB-Free India

Key Facts at a Glance

According to the PIB update dated 13 October 2026:

• 21%: Decline in India’s yearly emerging TB cases between 2015 and 2024, as reported by the government.
• 12%: Corresponding global decline over the same period.
• 92%: TB treatment coverage reported for India.
• 78%: Global TB treatment coverage cited in the update.
• 28.1 crore+: Cumulative screenings under the intensified TB Mukt Bharat Abhiyaan.
• 20 lakh+: Individuals provided TB Preventive Treatment (TPT).
• 5.7 lakh: New Nikshay Mitras added.
• 46,118: Gram Panchayats awarded TB-free certification.

These figures are from the cited government update and should be read with their stated time period and definitions. Screening totals, treatment coverage and changes in TB incidence measure different aspects of the public-health response.

1. What Is JOSH?

JOSH stands for Joint Squad for Health.

The campaign seeks to involve young people and local communities in India’s TB response. Its broad focus includes:

• Creating awareness about tuberculosis.
• Encouraging early detection and timely access to healthcare.
• Supporting patients in completing prescribed treatment.
• Reducing stigma and misinformation surrounding TB.
• Strengthening community participation in public-health efforts.

Why is community participation important?

TB control requires more than diagnosis and medicines. People may delay seeking medical attention because of stigma, financial difficulties, limited access to healthcare or a lack of awareness. Treatment interruption can also undermine recovery and contribute to the development of drug resistance.

Community-based awareness and patient support can help connect people with health services and improve treatment adherence.

Prelims takeaway: Remember the full form of JOSH and its focus on awareness, early detection, treatment adherence and stigma reduction.BIMSTEC Home Ministers’ Meeting 2026:

2. What Is Tuberculosis?

Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It most commonly affects the lungs, although it can also affect other organs.

How does TB spread?

TB spreads through the air when a person with infectious TB, particularly pulmonary TB, releases bacteria-containing aerosols while coughing or performing other respiratory activities.

It is not ordinarily spread through sharing food, handshakes or touching everyday objects.

Active TB and TB infection: Know the difference

TB infection: A person carries TB bacteria but does not have active TB disease. Such a person generally has no symptoms and is not infectious.

Active TB disease: The bacteria multiply and cause illness. Pulmonary TB can be infectious and may spread to others.

Some people with TB infection may develop active disease later, particularly when their immune defences are weakened. TB Preventive Treatment is used for eligible people at risk after appropriate clinical assessment and exclusion of active disease.

Common symptoms of active TB

• Persistent cough.
• Fever and night sweats.
• Unexplained weight loss.
• Fatigue or weakness.
• Chest pain; sometimes blood in sputum.

Anyone with concerning symptoms should seek medical assessment rather than relying on symptoms alone for diagnosis.

Official reference: WHO — Tuberculosis Fact Sheet

3. Major Government Initiatives Against TB

A. National TB Elimination Programme (NTEP)

The National TB Elimination Programme is India’s principal national programme for preventing, detecting and treating tuberculosis.

Its work includes diagnosis, treatment services, surveillance, prevention, patient support and public awareness.

B. TB Mukt Bharat Abhiyaan

The campaign seeks to accelerate India’s TB-control efforts through screening, early diagnosis, treatment support and community participation.

The PIB update cited more than 28.1 crore cumulative screenings under the intensified campaign.

C. Ni-kshay Mitra

Ni-kshay Mitra is associated with community support for people undergoing TB treatment under the TB Mukt Bharat initiative.

Support can include nutritional and other assistance, helping address social and economic barriers that may affect treatment and recovery.

D. TB Preventive Treatment (TPT)

TPT aims to prevent TB infection from progressing to active disease in eligible people at risk.

Before preventive treatment is started, healthcare providers must assess the individual and rule out active TB disease. The appropriate regimen depends on clinical guidance and the person’s circumstances.

Prelims distinction: Screening, diagnosis, treatment of active disease and preventive treatment are related but different interventions.

4. Technology and AI in TB Control

The PIB update highlighted technology-based interventions in India’s TB response.

Handheld X-ray screening

The government reported a 34-fold increase in X-ray screening through handheld units. Such equipment can support screening in settings where access to conventional diagnostic infrastructure may be limited.

A screening result is not necessarily a definitive diagnosis; appropriate follow-up testing and clinical assessment remain important.

TB Mukt Bharat App and AI chatbot

The government also highlighted the TB Mukt Bharat App and its AI chatbot, Khushi, alongside AI-based triage tools.

Potential applications of digital health tools include:

• Supporting access to information.
• Helping direct people towards appropriate services.
• Improving follow-up and communication.
• Supporting the identification of people who may need further assessment.

AI tools must complement—not replace—professional medical judgement, confirmatory diagnosis and patient privacy safeguards.

BPaLM regimen for drug-resistant TB

The PIB update also referred to the shorter BPaLM regimen for drug-resistant TB. BPaLM stands for:

• B — Bedaquiline
• Pa — Pretomanid
• L — Linezolid
• M — Moxifloxacin

The regimen is relevant to the treatment of eligible patients with drug-resistant TB under appropriate clinical protocols. It should not be confused with a general treatment regimen for every TB patient.

Prelims takeaway: Learn the expansion of BPaLM and distinguish drug-resistant TB treatment from preventive treatment.

5. What Do the Latest Figures Tell Us?

The government update reported that India’s decline in yearly emerging TB cases between 2015 and 2024 was greater than the corresponding global decline. It also reported higher treatment coverage in India than the global figure cited in the release.

These indicators suggest progress, but they do not mean that TB has been eliminated.

Important challenges remain:

1. Undetected cases: Some people may not be diagnosed promptly.
2. Drug resistance: Resistant TB requires appropriate diagnosis and specialised treatment.
3. Nutrition and poverty: Undernutrition and poor living conditions can increase vulnerability and complicate recovery.
4. Treatment adherence: Patients need sustained access to medicines, follow-up and support.
5. Stigma: Fear of discrimination may delay diagnosis or discourage treatment.
6. Access to healthcare: Remote and underserved communities may face barriers to screening and treatment.
7. Data interpretation: Screening numbers alone do not establish how many people have been diagnosed, cured or prevented from developing disease.

A comprehensive TB response therefore requires early detection, effective treatment, preventive services, social support and reliable monitoring.Hormuz Under Pressure:

6. UPSC Prelims: High-Yield Revision Notes

7. UPSC Prelims Practice: MCQs

Question 1

Consider the following statements about tuberculosis:

1. TB is caused by Mycobacterium tuberculosis.
2. TB commonly spreads through the air.
3. Every person infected with TB bacteria has active TB disease and can transmit it.

Which of the statements given above are correct?

A. 1 only
B. 1 and 2 only
C. 2 and 3 only
D. 1, 2 and 3

Answer: B. 1 and 2 only

Explanation: TB is caused by Mycobacterium tuberculosis and commonly spreads through the air. TB infection without active disease does not mean that a person is infectious.

Question 2

With reference to TB Preventive Treatment (TPT), consider the following statements:

1. It aims to reduce the risk of TB infection progressing to active disease in eligible people.
2. Active TB disease should be ruled out before preventive treatment is initiated.
3. TPT and treatment for active TB are interchangeable terms.

Which of the statements given above are correct?

A. 1 only
B. 1 and 2 only
C. 2 and 3 only
D. 1, 2 and 3

Answer: B. 1 and 2 only

Explanation: TPT is preventive care for eligible individuals. It is distinct from treatment for active TB disease.

Question 3

BPaLM, mentioned in the context of drug-resistant tuberculosis, includes which of the following medicines?

1. Bedaquiline
2. Pretomanid
3. Linezolid
4. Moxifloxacin

Select the correct answer:

A. 1 and 2 only
B. 1, 2 and 3 only
C. 2, 3 and 4 only
D. 1, 2, 3 and 4

Answer: D. 1, 2, 3 and 4

Explanation: All four medicines form the BPaLM regimen for eligible patients with drug-resistant TB under appropriate clinical guidance.

Question 4

Consider the following statements about the use of AI in public health:

1. AI-based triage can support the identification of people who may require further assessment.
2. An AI-generated assessment always replaces confirmatory diagnosis by healthcare professionals.
3. Digital health tools can support communication and follow-up.

Which of the statements given above are correct?

A. 1 only
B. 1 and 2 only
C. 1 and 3 only
D. 1, 2 and 3

Answer: C. 1 and 3 only

Explanation: AI can support screening, triage and follow-up, but it does not universally replace clinical assessment or confirmatory diagnosis.

Question 5

Consider the following statements about India’s TB-control response, as reported by the PIB on 13 October 2026:

1. India’s yearly emerging TB cases declined by 21% between 2015 and 2024.
2. The corresponding global decline cited in the update was 12%.
3. The government reported more than 28.1 crore cumulative screenings under the intensified TB Mukt Bharat Abhiyaan.

Which of the statements given above are correct?

A. 1 only
B. 1 and 2 only
C. 2 and 3 only
D. 1, 2 and 3

Answer: D. 1, 2 and 3

Explanation: All three figures were reported in the PIB update. Remember the reference period and source when revising current-affairs statistics.

8. Mains Linkage: GS Paper II

Practice question: “Community participation, early diagnosis and technological innovation are essential to improving public-health outcomes in India.” Discuss with reference to the country’s efforts to control tuberculosis.

Suggested answer framework:

• Introduction: Briefly explain TB as a major public-health challenge and outline the importance of prevention and treatment.
• Community participation: Discuss awareness, patient support, treatment adherence and stigma reduction.
• Early diagnosis: Explain the value of screening, diagnostic access and timely referral.
• Technology: Examine the potential of digital health tools, AI-supported triage and portable screening equipment.
• Challenges: Address drug resistance, undernutrition, missed diagnoses, unequal access and continuity of care.
• Way forward: Strengthen primary healthcare, reliable surveillance, patient-centred services, nutrition support and evidence-based implementation.
• Conclusion: Emphasise that technology and community participation work best when supported by accessible healthcare and sustained treatment.

9. Final Prelims Takeaway

For revision, prioritise these five areas:

1. JOSH — full form and objectives.
2. National TB Elimination Programme and TB Mukt Bharat Abhiyaan.
3. Difference between TB infection, active TB disease and TPT.
4. BPaLM and its four medicines.
5. Government-reported TB figures and the date of the PIB update.

These are syllabus-linked revision priorities, not predictions that any particular question will appear in the examination.

Editorial note: The MCQs in this article are original practice questions prepared for UPSC-style revision. They are not presented as actual previous-year UPSC questions.

GNM Global Nexus Media | UPSC Special
Current Affairs. Conceptual Clarity. Prelims Practice.